These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Cancer; 1996 Sep 15; 78(6):1284-92. PubMed ID: 8826952 [Abstract] [Full Text] [Related]
29. Cholesteatoma or keratoma: A pathological approach. Marquet J. Acta Otorhinolaryngol Belg; 1980 Jul 15; 34(1):5-11. PubMed ID: 7468193 [Abstract] [Full Text] [Related]
30. Cholesteatoma of the middle ear in human patients. An ultrastructural study. Schaper J, van de Heyning J. Arch Otolaryngol; 1976 Nov 15; 102(11):663-8. PubMed ID: 985197 [Abstract] [Full Text] [Related]
31. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma]. Sanković-Babić S, Sofronić-Milosavljević Lj. Srp Arh Celok Lek; 2000 Nov 15; 128(3-4):80-3. PubMed ID: 10932614 [Abstract] [Full Text] [Related]
33. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. de Jong JS, van Diest PJ, van der Valk P, Baak JP. J Pathol; 1998 Jan 15; 184(1):53-7. PubMed ID: 9582527 [Abstract] [Full Text] [Related]
34. Localization of interleukin-1 in human cholesteatoma. Ahn JM, Huang CC, Abramson M. Am J Otolaryngol; 1990 Jan 15; 11(2):71-7. PubMed ID: 2188520 [Abstract] [Full Text] [Related]
35. Why does middle ear cholesteatoma recur? Palva T, Mäkinen J. Arch Otolaryngol; 1983 Aug 15; 109(8):513-8. PubMed ID: 6870643 [Abstract] [Full Text] [Related]
36. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. de Jong JS, van Diest PJ, van der Valk P, Baak JP. J Pathol; 1998 Jan 15; 184(1):44-52. PubMed ID: 9582526 [Abstract] [Full Text] [Related]
37. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Shinoda H, Huang CC. Laryngoscope; 1995 Nov 15; 105(11):1232-7. PubMed ID: 7475882 [Abstract] [Full Text] [Related]
38. Transforming growth factor alpha localization and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Jindal SK, Snoey DM, Lobb DK, Dorrington JH. Gynecol Oncol; 1994 Apr 15; 53(1):17-23. PubMed ID: 8175016 [Abstract] [Full Text] [Related]
39. Colony-stimulating factor in middle ear cholesteatoma. Huang T, Yan SD, Huang CC. Am J Otolaryngol; 1989 Apr 15; 10(6):393-8. PubMed ID: 2688444 [Abstract] [Full Text] [Related]
40. The nature of the epithelium in acquired cholesteatoma. Lee RJ, Mackenzie IC, Hall BK, Gantz BJ. Clin Otolaryngol Allied Sci; 1991 Apr 15; 16(2):168-73. PubMed ID: 1712679 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]